These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4477565)

  • 21. Influence of chemotherapy and serum factors on the mitogenic response of peripheral leucocytes of leprosy patients to phytohaemagglutinin.
    Mehra VL; Talwar GP; Balakrishnan K; Bhutani LK
    Clin Exp Immunol; 1972 Oct; 12(2):205-13. PubMed ID: 4648820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the antibody response to sulfolipids in leprosy patients by 4,4'-diaminodiphenyl sulfone (DDS).
    Malik U; Khuller GK; Kumar B
    Antonie Van Leeuwenhoek; 1983 Dec; 49(6):579-83. PubMed ID: 6370132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
    Anderson R; Gatner EM; van Rensburg CE; Grabow G; Imkamp FM; Kok SK; van Rensburg AJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):495-503. PubMed ID: 6264848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
    Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections.
    Fitzgerald MG; Hosking CS
    Immunology; 1976 Jan; 30(1):33-42. PubMed ID: 129433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the self administration of DDS in Gudiyatham Taluk.
    Jesudasan K; George B; Chacko CJ; Taylor PM; Kurian PV; Job CK
    Lepr India; 1976 Oct; 48(4 Suppl):668-76. PubMed ID: 1026802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of phytohemagglutinin-stimulated lymphocyte transformation by neutral SH-dependent proteinase of the spleen].
    Baranova FS; Lokshina LA; Gureeva TA; Popova LK; Zaretskaia IuM
    Biull Eksp Biol Med; 1979 Sep; 88(9):324-6. PubMed ID: 519024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressive effect of plasma on lymphocyte transformation in nodular lepromatous leprosy.
    Ramos Zepeda R; Gonzalez Mendoza A; Morales Ortiz R
    Bull Soc Pathol Exot Filiales; 1984; 77(2):182-9. PubMed ID: 6722968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of rifampicin on the lymphocyte stimulation (author's transl)].
    Kramer H; Bergmann KC
    Z Erkr Atmungsorgane; 1976; 144(2):163-7. PubMed ID: 969698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary dapsone resistant leprosy in Nepal.
    Samuel NM; Samuel S; Loudon J; Adiga RB
    Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
    Almeida JG; Chacko CJ; Christian M
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular localization of dapsone and rifampicin in skin and nerve of multidrug treated leprosy patients.
    Save MP; Shetty VP; Antia NH
    Indian J Lepr; 1995; 67(3):273-84. PubMed ID: 8576606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vivo and in vitro effects of levamisole in patients with lepromatous leprosy.
    Sher R; Wadee AA; Joffe M; Kok SH; Imkamp FM; Simson IW
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):159-66. PubMed ID: 7196885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.